Last reviewed · How we verify
Chronocort: fasted
At a glance
| Generic name | Chronocort: fasted |
|---|---|
| Also known as | modified release hydrocortisone |
| Sponsor | Neurocrine UK Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of Slow Release Hydrocortisone on Fed & Fasting Volunteers; Immediate Release on Fasting Only (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chronocort: fasted CI brief — competitive landscape report
- Chronocort: fasted updates RSS · CI watch RSS
- Neurocrine UK Limited portfolio CI